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RIPK1 can mediate apoptosis in addition to
necroptosis during embryonic development
Xuhua Zhang1, John P. Dowling1 and Jianke Zhang 1
Abstract
RIPK1 has emerged as a key effector in programmed necrosis or necroptosis. This function of RIPK1 is mediated by its
protein serine/threonine kinase activity and through the downstream kinase RIPK3. Deletion of RIPK1 prevents
embryonic lethality in mice lacking FADD, a signaling adaptor protein required for activation of Caspase 8 in extrinsic
apoptotic pathways. This indicates that FADD-mediated apoptosis inhibits RIPK1-dependent necroptosis to ensure
successful embryogenesis. However, the molecular mechanism for this critical regulation remains unclear. In the
current study, a novel mouse model has been generated, by disrupting a potential caspase cleavage site at aspartic
residue (D)324 in RIPK1. Interestingly, replacing D324 with alanine (A) in RIPK1 results in midgestation lethality, similar
to the embryonic defect in FADD−/− mice but in stark contrast to the normal embryogenesis of RIPK1−/− null mutant
mice. Surprisingly, disrupting the downstream RIPK3 alone is insufﬁcient to rescue RIPK1D324A/D324A mice from
embryonic lethality, unless FADD is deleted simultaneously. Further analyses reveal a paradoxical role for RIPK1 in
promoting caspase activation and apoptosis in embryos, a novel mechanism previously unappreciated.
Introduction
Apoptosis is a major form of programmed cell death
(PCD) and is executed by Caspases1. When PCD signaling
pathways become dysregulated, developmental defects
can occur at embryonic or postnatal stages. While apop-
tosis has been studied since the 1970s, necroptosis is a
recently described form of PCD that is usually kept
latent2–5. When apoptosis is disrupted, cell death signal-
ing skews towards necroptosis, in which receptor inter-
acting protein kinase 1 (RIP, RIP1 or RIPK1) and
RIPK3 serve as key signaling effectors6–10. These two
protein serine/threonine kinases interact with one
another via their RIP homotypic interaction motif. This
results in phosphorylation of both RIPK1 and RIPK3,
leading to recruitment and activation of the mixed lineage
kinase domain like (MLKL) protein. Once activated,
MLKL translocates to and disrupts the plasma mem-
brane11,12. Loss of membrane integrity during necroptosis
results in the release of cellular contents, leading to
inﬂammatory responses13.
In the immune system, PCD is required for maintaining
homeostasis and suppression of autoimmunity14. The
extrinsic pathway is triggered by the death receptors (DRs)
including Fas and TNFR1, in which the FADD adaptor
recruits Caspase 8, leading to apoptosis. RIPK1 has long
been studied as a mediator of NFκB activation during pro-
survival and pro-inﬂammatory signaling, until it became
evident that RIPK1 also plays a role in an alternative death
pathway, necroptosis, especially when apoptosis is com-
promised in various cell lines6,7,15. Studies by us and others
provide evidence that RIPK1 and RIPK3-mediated
necroptosis indeed occurs in vivo16–19, which helps
explain the initial paradoxical observations of embryonic
lethality in FADD−/− or Caspase 8−/− mice20–22. More-
over, RIPK1-mediated necroptosis leads to defect in
mature T and B lymphocytes lacking FADD or Caspase
816,23,24. In total, these data indicate that successful
embryogenesis and normal TCR-induced proliferative
responses require FADD-mediated suppression of RIPK1
and RIPK3-dependent necroptosis in vivo.
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RIPK1-mediated necroptosis also occurs in neuronal
cells, which leads to neurodegenerative pathologies3.
Apoptotic cells are engulfed by phagocytic cells, which
prevents spillage of intracellular contents, and thus limits
tissue damage and inﬂammation14,25,26. Therefore, there is
a clear beneﬁt for avoiding necrosis. Currently, it remains
unclear how FADD-mediated signaling keeps RIPK1-
mediated necroptosis latent. One possibility is that RIPK1
is disabled via cleavage by Caspase 8 activated through
FADD. Indeed, an earlier study indicated aspartic acid
residue (D)324 of RIPK1 being targeted by Caspase 827.
However, this study argues that cleavage of RIPK1 by
Caspase 8 promotes apoptosis, and there is currently a
lack of deﬁnitive in vivo evidence to support this model or
suggest an alternative mechanism. To address this para-
dox, we have developed a novel mouse model using
CRISPR/Cas9-mediated gene editing to inactivate a pre-
dicted caspase cleavage site within the intermediate
domain of RIPK1. Our data reveals a new mechanism in
the regulation of RIPK1, indicating that RIPK1 resistance
to Caspases not only facilitates necroptosis, but also
promotes apoptosis in mouse embryos.
Results
Targeting the predicted Caspase 8 cleavage site in RIPK1
through CRIPSR/Cas9-mediated gene editing
A potential mechanism for suppression of RIPK1-
dependent necroptosis is that FADD-mediated activa-
tion of caspases may lead to cleavage of RIPK1. A previous
in vitro study indicated that RIPK1 could be a target of
Caspase 827. In particular, Caspase 8 appears to cleave
RIPK1 in vitro at aspartic acid (D) residue 324. To test this
potential mechanism in vivo, we generated a novel mouse
model in which D324 in RIPK1 was replaced with alanine
(A) through the CRISPR/Cas9-mediated gene editing
strategy28. DNA sequencing analysis of the founder mice
in the C57BL/6 background conﬁrmed the resulting
D324A mutation (Supplementary Fig. S1). We found that
the heterozygous RIPK1+/D324A founders were fertile, and
when backcrossed with C57BL/6 mice, transmitted the
a
RIPK1 +/+     +/D324A   D324A/D324A Total
At weaning Actual      45         83 0 128
Expected   45          90 45 180
At birth Actual      9           15 0 24
Expected   9            18               9 36
Postnatal offspring of RIPK1+/D324A intercrosses
RIPK1+/+ RIPK1D324A/D324A
b Embryos of RIPK1+/D324A intercrosses
c d RIPK1+/+ RIPK1D324A/D324A
RIPK1 +/+     +/D324A   D324A/D324A Total
E14.5
E12.5
Actual        14        21 0 35      
Expected       14 28                  14 56
Actual       20  33 7                60
Expected       20          40 20 80
Fig. 1 Analysis of the impact of the RIPK1 D324A mutation on postnatal and embryogenic development in mice. RIPK1+/D324A heterozygous
mutant mice undergo normal development, and were intercrossed. Genetic analyses of the offspring at weaning age or at birth (a), and at the
indicated gestation stages (b), were performed. The RIPK1D324A/D324A homozygous mutants were detected at E12.5, but not at E14.5, at birth or at
weaning age. Representative images of whole embryos (c) and H&E staining of embryo sections (d) of mutant and wild type control embryos at
E12.5. The ruler division in mm is shown to the left of embryos in (c). Scale bars in (d)= 1 mm
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mutant allele to the offspring. We found that hetero-
zygous RIPK1+/D324A mutant mice contained normal
numbers of T cells and B cells in the primary and sec-
ondary lymphoid organs (data not shown). This indicates
that the D324A mutation does not impose a dominant-
negative effect.
We then carried out intercrosses of the heterozygous
RIPK1+/D324A mice. Interestingly, no homozygous
RIPK1D324A/D324A mutant mice were detected in the off-
spring at the weaning age (Fig. 1a, top) or at birth (Fig. 1a,
bottom). This data indicates that RIPK1D324A/D324A
mutant mice die before birth. Therefore, we performed
timed mating analyses, but again found no homozygous
RIPK1D324A/D324A mutant embryos at embryonic (E) day
14.5 from intercrosses of heterozygous RIPK1+/D324A
mutant mice (Fig. 1b, top). Further analysis of earlier
stages showed that RIPK1D324A/D324A embryos were pre-
sent at E12.5, albeit at lower than the predicted Mendelian
ratios (Fig. 1b, bottom). When compared with wild type
control E12.5 embryos, the RIPK1D324A/D324A mutant
E12.5 embryos had a clear developmental defect (Figs. 1c,
d). These data indicate that the D324A mutation in RIPK1
results in embryonic lethality around E12.5. This obser-
vation is in sharp contrast to normal embryogenesis in
RIPK1−/− null mutant mice, as previously reported16.
RIPK1D324A/D324A embryonic death is partially dependent
on RIPK3
To facilitate further analysis, we prepared mouse
embryonic ﬁbroblasts (MEFs). Interestingly, D324A
mutant MEFs displayed dramatically poor viability in
culture (Fig. 2a) and we were unable to obtain a sufﬁcient
number of cells for further analysis. However, we found
that deletion of one allele of RIPK3 improved viability of
D324A mutant MEFs (Fig. 2b). We then performed real-
time analysis of cell death responses using an IncuCyte
system, and found that RIPK1D324/D324 RIPK3+/− MEFs
were highly sensitive to cell death induction by TNFα over
a 24 h period, as shown by uptake of Sytox Green, whereas
RIPK1+/+ RIP3K+/− control MEFs were highly resistant
to the cell death induction (Fig. 2c). Snapshot images of
cell death at 0 h and 24 h post TNFα treatment also
allowed for direct visualization of the greatly increased
cell death in RIPK1D324/D324 RIPK3+/− MEFs, compared
with RIPK1+/+ RIPK3+/− control MEFs (Fig. 2d).
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Fig. 2 The RIPK1 D324A mutation leads to hypersensitivity to cell
death responses. Images of MEFs with indicated genotypes
prepared from RIPK1+/D324A mouse intercross a or from RIPK1+/D324A
RIPK3+/− mouse intercrosses (b). MEF cells of the indicated genotypes
were cultured in the presence of SYTOX Green (50 nM), with or
without TNFα (50 ng/ml) for 24 h (c). Real-time analysis was performed
with an IncyCyte unit instrument. Dying cells are indicated as SYTOX
Green+/mm2) and plotted against the indicated time-points. SEM
were indicated by errors bars. d Real-time imaging analysis of MEFs
treated with TNFα (50 ng/ml) and SYTOX Green (50 nM). Increased cell
death is indicated by higher numbers of SYTOX Green+ cells in
RIPK1D324A/D324A RIPK3+/− MEF, compared to RIPK1+/D324A RIPK3+/−
control. The data represent at least three independent experiments.
Scale bars in (a) and (b)= 100 μm, and in (d)= 300 μm
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To determine whether embryonic death in
RIPK1D324A/D324A mice is due to RIPK3-mediated
necroptosis, RIP1K+/D324A mice were crossed to mice
lacking RIPK3. The resulting RIPK1+/D324A RIPK3−/−
mice were intercrossed and genetic analysis of the off-
spring was performed. At weaning age, we detected no
viable RIPK1D324A/D324A RIPK3−/− double mutant mice
(Fig. 3a, top). Therefore, we analyzed embryos generated
from RIPK1+/D324A RIPK3−/− mouse intercrosses and
found that RIPK1D324A/D324A RIPK3−/− double mutant
embryos were present from E12.5 to E17.5 (Fig. 3a,
bottom). Although RIPK1D324A/D324A RIPK3−/− double
mutant embryos appeared normal at E12.5 (Fig. 3b), they
displayed an apparent defect by E17.5 (Fig. 3c), as
compared to RIPK1+/+ RIPK3+/+ control embryos.
Histological analysis revealed cell death at E17.5 in
RIPK1D324A/D324A RIPK3−/− embryos, compared to
RIPK1+/+ RIPK3−/− control embryos (Fig. 3d). In total
these data indicate that RIPK3-mediated necroptosis is
partially responsible for death in RIPK1D324A/D324A
embryos.
Analysis of RIPK3-independent pathway unleashed in
RIPK1D324A/D324A mice
It is interesting that lack of RIPK3 fails to restore nor-
mal embryogenesis in RIPK1D324A/D324A mice, indicating
a
cRIPK1+/+RIPK3-/- RIPK1D324A/D324ARIPK3-/- RIPK1+/+RIPK3-/- RIPK1D324A/D324ARIPK3-/-
d RIPK1+/+RIPK3-/- RIPK1D324A/D324ARIPK3-/-
Genotype RIPK1 +/+ +/D324A D324A/D324A RIPK3-/- Total
At weaning Actual 18 48 0 64 64
Expected 18 36 18 72 72
E12.5-17.5 Actual 19 47 14 80 80
Embryos Expected 19 38 19 80 80
E18.5-birth Actual 6 14 0 20 20
Expected 5 10 5 20 20
b
Fig. 3 RIPK3-mediated necroptosis does not entirely explain the embryonic lethality in RIPK1D324A/D324A mice. Genetic analysis indicated that
RIPK3 deletion was unable to correct the developmental defect, because no viable RIPK1D324A/D324A RIPK3−/− mice were detected at weaning age
(a, upper rows). Analyses of embryos from timed mating show that RIPK1D324A/D324A RIPK3−/− embryos can be found as late as E17.5 (a, lower rows).
Images of embryos of indicated genotypes at E12.5 (b) and E17.5 (c). RIPK1D324A/D324A RIPK3−/− embryos appear normal at E12.5 (b), unlike the defect
in E12.5 RIPK1D324A/D324A (Fig. 1c). However, severe defect in RIPK1D324A/D324A RIPK3−/− embryos became apparent at E17.5 (c). Histological analysis
via H&E staining of the embryos at E17.5 revealed major cell death in the RIPK1D324A/D324A RIPK3−/− embryo, contrasting the normal histology in
RIPK1+/+ RIPK3−/− control (d). Tissues shown represent the fetal liver areas. The ruler division in mm is shown to the left of embryos in (b), (c). Scale
bars in (d)=100 μm.
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that a RIPK3-independent pathway is also responsible in
part for death at E17.5. During further analysis of the
defect in RIPK1D324A/D324A mice, we performed immu-
nohistochemistry (IHC) assays and found that Caspase
activities were greatly elevated in RIPK1D324A/D324A
RIPK3−/− embryos, compared to RIPK1+/+ RIPK3−/−
embryo control (Fig. 4a). We also analyzed MEFs treated
with TNFα using the IncuCyte system for real-time
simultaneous detection of cell death and caspase activ-
ities. RIPK1D324A/D324A RIPK3−/− MEFs were hypersen-
sitive to TNFα-induced death, as indicated by Sytox
Green uptake (Fig. 4b, left). However, since RIPK3-
mediated necroptosis is blocked in RIPK1D324A/D324A
RIPK3−/− MEFs, an alternative form of cell death is
occurring. Agreeing with IHC analysis (Fig. 4a), drama-
tically higher levels of caspase 3/7 activities were detected
in RIPK1D324A/D324A RIPK3−/− MEFs than in control
RIPK1+/+ RIPK3−/−MEFs after TNFα treatment (Fig. 4b,
right). These data in total suggest a skewing towards
apoptotic responses in embryonic cells when RIPK1 is
resistant to Caspase 8 via the D324A point mutation and
necroptosis is blocked through knockout of RIPK3.
FADD recruits and facilitates Caspase 8 activation
during DR-mediated signaling. Given elevated Caspase
activation in RIPK1D324/D324A embryos, it is possible
that the D324A mutation in RIPK1 facilitates extrinsic
apoptosis. To test this, the FADD knockout allele was
crossed into RIPK1D324A/D324A mice. However, deletion
of FADD provides little improvement to the develop-
ment of RIPK1D324A/D324A embryos and vice versa.
RIPK1D324A/D324A FADD−/−, RIPK1D324A/D324A
FADD+/+ and FADD−/− mutant embryos displayed
similar developmental blockage (Fig. 5a).
We then determined the effect of simultaneous inactiva-
tion of both RIPK3 and FADD. To this end, RIPK1+/D324A
RIPK3+/− FADD+/− triple heterozygous (THZ) mutant
mice were intercrossed. This mating produced no viable
RIPK1D324A/D324A RIPK3−/− mice containing one or both
alleles of endogenous FADD. However, viable RIPK1D324A/
D324A FADD−/− RIPK3−/− triple mutant mice were detec-
ted at weaning age (Fig. 5b). Western blot analysis of total
splenocytes conﬁrmed the presence or absence of RIPK1,
RIPK3, and FADD protein (Fig. 5d). The resulting triple
mutant mice reached adulthood with weight gain similar to
wild type control mice as well as FADD−/− RIPK3−/−
(DKO) mice (Fig. 5c), and they were fertile. In total, these
data indicate that the D324A mutation of RIPK1 promotes
both FADD-dependent apoptosis and RIPK3-dependent
necroptosis, thus leading to embryonic lethality at
midgestation stages, similar to FADD−/− embryonic defect.
This is in sharp contrast to RIPK1−/− null mice, which
undergo normal embryonic development but die soon after
birth.
The impact of RIPK1 D324A mutations on lymphoid
compartment
Earlier studies have shown that disruption of the func-
tion of FADD by using a FADD-DN mutant or by deletion
of FADD in aged RIPK3−/− mice leads to a greatly
exaggerated lpr-like symptom16,19,24. We found that the
lpr phenotype, characterized as lymphadenopathy and
splenomegaly, became apparent in FADD−/− RIPK3−/−
double knockout (DKO) mice past 3 months of age
(Fig. 6a, middle). A similar lpr-like phenotype was present
in RIPK1D324A/D324A FADD−/− RIPK3−/− triple mutant
mice, compared to wild type control mice (Fig. 6a). This
signature lpr phenotype was comparable between TM
mice and DKO mice.
Flow cytometric analyses shows that DKO mice contain
the unique subset of CD3+ T cells that express the B cell
marker B220 (Fig. 6b), a signature phenotype of the Fas−/−
lpr mutant mice. Furthermore, these T cells lose the
SYTOX Green Caspase3/7 Red
a
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Fig. 4 Caspase activities were greatly elevated in RIPK1D324A/D324A
RIPK3−/− embryos. Immunohistochemistry analyses of E17.5 embryos
of the indicated genotypes through staining with antibodies speciﬁc to
cleaved Caspase 3 (a). Tissues shown represent the fetal liver areas.
MEFs cells were treated with TNFα (50 ng/ml), and SYTOX Green (50
μM) was added to detect cell death (b). At 14 h, Caspase-3/7 red (5 μM)
was added and two-color, real-time imaging was performed using an
IncuCyte system at 24 h. Increased cell death (Green+, lower left)
correlates with increased Caspase 3/7 activities (red+, lower right) in
RIPK1D324A/D324A RIPK3−/− MEFs, when compared with RIPK1+/+
RIPK3−/− control MEFs. Scale bars in (a)= 100 μm, and in (b)= 300 μm
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expression of CD4 and CD8 (Supplementary Fig. S3a).
When absolute numbers of this peculiar T cell population
were determined, DKO and TM mice at ages 3–6 months
contain dramatically higher numbers of CD3+B220+
T cells (Fig. 6c). Moreover, the numbers of conventional
T cells CD3+B220− T cells and B cells are also
signiﬁcantly increased in the lymph nodes in DKO and
TMmice (Supplementary Figs. S3b,c). In young adult mice
(6 week old), the thymus, spleen and lymph nodes of
RIPK1D324A/D324A FADD−/− RIPK3−/− TM mice were
similar in size and weight to that of FADD−/− RIPK3−/−
DKO or wild type control mice (Supplementary Fig. S4a).
Flow cytometric analysis revealed no obvious defect in the
T cell and B cell lineages of TM mice, compared to DKO
or wild control mice (Supplementary Figs. S4b, c).
Death receptor signaling in RIPK1D324A/D324A mutant mice
The extrinsic cell death pathways mediated by DRs are
essential for immune homeostasis, as indicated by the Fas−/
− lpr mouse model. We showed previously that when
RIPK1 was absent, thymocytes underwent normal Fas-
induced death, but became hypersensitive to TNFα-induced
death29. In contrast, RIPK1−/− FADD−/− thymocytes were
resistant to TNFα, similar to wild type thymocytes16. In
order to determine the status of the DR pathways in TM
mice, thymocytes were isolated and treated with various
stimuli to initiate extrinsic cell death. Similar to DKO thy-
mocytes, TM thymocytes were highly resistant to cell death
responses induced by Fas (Fig. 7a). Unlike hypersensitivity
in RIPK1−/− thymocytes16, TM and DKO thymocytes were
resistant to TNFα-induced cell death (Fig. 7b). TNFα can
also trigger activation of the NFκB pathway and MAPK
signaling events in a RIPK1-dependent manner. However,
we found that these pathways were not affected in
RIPK1D324A/D324A MEFs cells treated with TNFα (Fig. 7b),
indicating that the D324A mutation leads to a selective loss
of function for RIPK1, essential for mouse embryogenesis.
In contrast, loss of the entire RIPK1 protein results in
severely impaired activation of NFκB and MAPKs Erk1/2
activation (Fig. 7b, bottom).
Discussion
During embryonic development, RIPK1 can promote
necroptosis, which is suppressed by FADD. This reg-
ulatory mechanism was demonstrated by our previous
data showing that ablation of RIPK1 rescues FADD−/−
mice from embryonic lethality16. The resulting FADD−/−
RIPK1−/− DKO mice undergo normal embryonic
b
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DKO TM
c
a RIPK1D324A/D324A RIPK1D324A/D324A FADD-/-Wild type RIPK1+/+ FADD-/-
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Fig. 5 Normal development is restored by simultaneous deletion of both FADD and RIPK3 in RIPK1D324A/D324A mice. Analysis was performed
to determine the effect of disrupting FADD-mediated apoptosis. Defects in the three mutant E12.5 embryos of the indicated genotypes are similar,
contrasting normal embryos in the wild type control (a). The ruler division in mm is shown to the left of embryos. At two-month age, RIPK1D324A/
D324A RIPK3−/− FADD−/− (TM) mice are indistinguishable in appearance (b) and in body weights (c) from the wild type (WT) and RIPK3−/− FADD−/−
(DKO) control mice. Western blot analysis of total splenocytes conﬁrming presence or absence of RIPK1, RIPK3, and FADD proteins (d). Ponceau S
staining (pink) was performed as protein loading and transfer control
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development. The current study aims to understand the
mechanism for how RIPK1-mediated necroptosis in
embryos is suppressed by FADD, an adaptor for Caspase 8
activation. To this end, we performed gene editing of
RIPK1 in mice in an in vivo analysis of a potential
mechanism that RIPK1 could be cleaved by Caspase 8
activated through FADD. Our current study reveals novel
insight by providing in vivo evidence that besides playing
an effector role in necroptosis in embryos, RIPK1 may
actually promote apoptosis.
Firstly, mutating the Caspase cleavage site D324 of
RIPK1 led to embryonic lethality (Fig. 1). The fact that
RIPK1D324A/D324A mutant mice die much earlier than
RIPK1−/− null mice, but similar to FADD−/− embryonic
death at E12.5 suggests that the D324A mutation ren-
dered RIPK1constitutively active and readily promoted
RIPK3-dependent necroptosis. Indeed, severe loss of cells
was seen in RIPK1D324A/D324A embryos (Figs. 1b, c), and
there was poor ex vivo survival of RIPK1D324A/D324A MEFs
(Fig. 2a). Remarkably, deleting one allele of RIPK3 greatly
improves RIPK1D324A/D324A MEF growth (Fig. 2b).
Deleting both alleles of RIPK3 prolongs embryonic
development to E17.5, indicating that RIPK1D324A/D324A
embryos die, due in part to RIPK3-mediated necroptosis.
However, these embryos do not survive to birth (Fig. 3).
This observation was unexpected, especially given that
RIPK1−/− or FADD−/− RIPK1−/− embryos undergo full
term gestation, and no death occurs until after birth16.
A plausible explanation for this paradoxical observation
is that the D324A mutation in RIPK1 skews response to
another cell death pathway. To this end, we found ele-
vated CC3 levels present in RIPK1D324A/D324A RIPK3−/−
embryos and TNFα-treated MEFs (Fig. 4), indicating that
apoptosis may also occur in RIPK1D324A/D324A RIPK3−/−
embryos. In further support of this notion, we found that
RIPK1D324A/D324A RIPK3−/− MEFs were hypersensitized
to apoptotic death in responses to treatment with TNFα
(Fig. 4b). However, deletion of FADD alone does not
provide any improvement on embryogenesis (Fig. 5a). It is
only when both FADD and RIPK3 are absent that normal
development is ensured in RIPK1D324A/D324A mice
(Fig. 5b). This striking observation illustrated the unique
power of the new RIPK1D324A/D324A mouse model, which
reveals a novel function of RIPK1 in protecting embryos
from apoptosis. This newly discovered function of RIPK1
during embryogenesis has not been appreciated using the
previously described RIPK1−/−, or FADD−/− RIPK1−/− or
FADD−/− RIPK1−/− RIPK3−/− mice. In total, we deter-
mined that Caspase cleavage of RIPK1 not only protects
against necroptosis, but also RIPK1-dependent apoptosis.
In contrast to the perinatal lethality of FADD−/−
RIPK1−/− mice16, FADD−/− RIPK3−/− DKO mice have
normal embryonic and postnatal development by block-
ing not only RIPK3-dependent necroptosis, but also
FADD-independent apoptosis19. RIPK1D324A/D324A mice
also survive to adulthood when both FADD and
RIPK3 are knocked out (Fig. 5). These ﬁndings provide
an additional platform to determine if caspase cleavage
of RIPK1 has a cell death-independent role. To this
a
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Fig. 6 Analysis of the lymphoid compartments in TM mice.
Representative images of the thymus, lymph nodes, and spleen of 3-
month-old mice of the indicated genotypes show that the TM mice
develop the signature lpr phenotype, comparable to that in DKO mice,
as indicated by lymphadenopathy and splenomegaly (a). The ruler
division in mm is shown to the bottom. Wild type control is shown
(left). Two color ﬂow cytometry analysis show that the typical CD3+
B220+ T cell population accumulates in the peripheral lymphoid
organs in TM and DKO mice, contrasting the wild type control mouse
(b). Scatter plots of total number of CD3+B220+ T cells of 3-month-old
mice of the indicated genotypes (c). *p < 0.05; **p < 0.01; ***p < 0.001;
ns not signiﬁcant. Wild type (WT), double knockout mouse (DKO), and
triple mutant (TM) mice are the same as in (a), (b)
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end, the RIPK1D324A/D324A FADD−/− RIPK3−/− TM and
FADD−/− RIPK3−/− DKO mice are comparable to wild
type mice at young adult age (Supplementary Fig. S4)
and develop progressive lymphadenopathy and spleno-
megaly, when aged, displaying the lpr-like phenotype
(Fig. 6 and Supplementary Fig. S3).
Although RIPK1 is isolated as a Fas-interacting protein,
its absence does not impact Fas-induced apoptosis30,31.
Instead, RIPK1 deﬁciency is most often associated with
defective NFκB activation induced by TNFR132. Deletion
of TNFR1 does not apparently affect mouse development,
but RIPK1 deﬁciency leads to perinatal lethality31. This
paradox remained unresolved until recent studies showed
that RIPK1−/− mice can survive into late adulthood only
when apoptosis is blocked by deletion of FADD or Cas-
pase 8 and necroptosis is blocked by deletion of
RIPK319,33–35. This ﬁnding implies that RIPK1 suppresses
both FADD/Caspase 8-mediated apoptosis and RIPK3-
mediated necroptosis at the perinatal stage.
RIPK1 has several putative functional domains, and
each has been proposed to play important roles in distinct
signaling pathways. Our current study employs a targeted
and speciﬁc approach to answer a question, untestable
through the previous models including RIPK1−/− mice
lacking the entire RIPK1 protein. We found that although
RIPK1D324A/D324A cells are hypersensitive to both
necroptosis and apoptosis induction by TNFα, the Fas-
induced cell death pathway was not affected by the D324A
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Fig. 7 Analysis of the effect of the D324A mutation on DR-induced signaling pathways. a Thymocytes from mice of indicated genotypes were
treated with various doses of anti-Fas antibodies (left) or TNFα (right) for 16 h and cell death was determined by PI uptake measured using a ﬂow
cytometer. b MEFs of the indicated genotypes were stimulated with TNFα (10 ng/ml) and induction of phosphorylation of p65 NFκB and Erk1/2 was
analyzed by western blotting with the corresponding antibodies. Probing of the same membrane with antibodies for total NFκB or Erk1/2 protein
was performed as protein loading/transfer control
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mutation in RIPK1 (Fig. 7a). Furthermore, non-cell death
pathways induced by TNFα, such as activation of the
NFκB and MAPK signaling were also not impacted
(Fig. 7b). In particular, our data revealed a novel role for
RIPK1 in promoting apoptosis in embryos. Previous
in vitro/ex vivo study suggested that RIPK1 cleavage by
Caspase 8 facilitate apoptosis in cell lines27. Our current
study provides the ﬁrst direct in vivo evidence that FADD-
Caspase 8 disable RIPK1 through cleavage at D324, and as
a result, protect embryonic cells against not only
necroptosis but also apoptosis. RIPK1-dependent apop-
tosis induced by TNFα has been previously shown to
occur in other settings32,36–42. A more recent study shows
that a highly ubiquitinated, insoluble form of RIPK1 is
important for apoptotic signaling and identiﬁes new
players regulating RIPK1-dependent apoptosis43. Previous
studies have shown that the inhibitor cFLIP not only
blocks apoptosis, but also necroptosis44. One possibility is
that a cFLIP-caspase 8 heterodimmer blocks not only
RIPK1-dependent necroptosis17 but also RIPK1-
dependent apoptosis via a caspase 8 homodimer. Inter-
estingly, in proximity to D324, S321 can be phosphory-
lated by MK2, which helps suppress RIPK1-dependent
apoptosis and necroptosis, as shown in recent studies45,46.
Therefore, several regulatory mechanisms target the
intermediate region of RIPK1. The implications of the
current study are wide ranging and could be studied in the
context of cancer by inducing necroptosis in cancer cells
through preventing RIPK1 cleavage or autoimmune and
inﬂammatory diseases, where RIPK1 cleavage could be
induced to prevent necroptosis.
Materials and methods
Mice
A previously described strategy28 was employed to
generate RIPK1+/D324A founder mice, through CRISPR/
Cas9-mediated gene editing in the C57BL/6 background
using the guide RNA 5′-CCTGAATTTGACCTGCTCGG
AGG-3′. RIPK3−/− mice were kindly provided by Drs.
Kim Newton and Vishva Dixit at Genentech47. FADD+/−
mice have been described in our previous studies16,20. All
animal studies were approved by Institutional Animal
Care and Use Committee (IACUC) at Thomas Jefferson
University. Genotyping of RIPK1+/D324A mice was per-
formed using the primers: 5′-AGAATGTTTTCACTGCA
GCATGAC-3′ and 5′-GGTACACAGACTCAGACACA
CATAC-3′ for the endogenous allele; 5′-AATGTT
TTCACTGCAGCATGCT-3′ and 5′-GGTACACAGAC
TCAGACACACATAC-3′ for the D324A mutant allele.
RIPK1+/D324A mice were intercrossed and the resulting
offspring at various embryonic stages and the weaning age
were genotyped by PCR. For embryo analysis, timed
mating were set up with RIPK1+/D324A mice in the eve-
ning and females were checked in the morning. When
vaginal plug was detected, embryos were designated E0.5.
Embryos were isolated from pregnant mice at various
gestation stages and genotypes were determined by PCR
analyses. Genotyping information for additional gene
alleles is shown in Supplementary Fig. S2.
Cell culture
Mouse embryonic ﬁbroblasts (MEFs) were isolated from
E10.5 to E12.5 embryos. Embryos of the desired genotypes
were placed in 24-well plates with trypsin (0.25%), chop-
ped up with scissors or a scalpel blade. The resulting
tissues pieces (1–2mm3) were further sheared by pipet-
ting up and down several times, and then incubated at
37 °C, 5% CO2 for 10min. The digested embryonic tis-
sues/cells were cultured in DMEM medium containing
FBS (10%), L-Glutamine (2 mM), penicillin (100 U/mL),
streptomycin (100 μg/mL), and β-mercaptoethanol (100
μM), at 37 °C with 5% CO2. Thymocytes and peripheral
T cells were isolated from the spleen and lymph nodes
and were cultured in RPMI medium containing FBS
(10%), L-Glutamine (2 mM), penicillin (100 U/mL),
streptomycin (100 μg/mL), and β-mercaptoethanol
(5 μM).
Immunohistochemistry analysis
Embryos were ﬁxed in 10% buffered formalin for 2 days,
were then washed 2–3 times with PBS and transferred to
70% ethanol, and ﬁnally embedded in parafﬁn. Sections
were stained with hematoxylin and eosin or with anti-
bodies speciﬁc for activated/cleaved caspase 3 (Cell Sig-
naling Technology #9661).
Flow cytometry
Lymph nodes, spleen and thymus were isolated during
mouse dissection. Single cell suspension was prepared and
red blood cells were depleted by hypotonic lysis. Cells
were stained on ice for 30 min in PBS containing 3% BSA,
1 mM EDTA, and 0.05% sodium azide with
ﬂuorochrome-conjugated antibodies anti-CD3 (BD Bios-
ciences, clone 17A2), anti-CD4 (BD Biosciences, clone
GK1.5), anti-CD8 (Caltag, clone CT-CD8a), anti-B220
(Caltag, clone RA3–6B2). Samples were washed twice
with PBS. Data was acquired on LSR II ﬂow cytometric
analyzer (BD Biosciences) and analyzed using FlowJo
software (Treestar). Total cell numbers were counted on
Countess Automated Cell Counter (Invitrogen) and
lymphocyte cellularity was determined by multiplying the
total cell number of indicated organ by percentage of
CD3+ or B220+ cells within the organ obtained by ﬂow
cytometry.
Cell death assays
Thymocytes (105/well) were seeded in triplicate in 96-
well ﬂat-bottom plates in complete RPMI with various
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concentrations of anti-Fas antibody (BD Biosciences,
clone Jo2) or TNFα. After incubation for 16 h, 1 μg/ml
propidium iodide (PI) and the percentage of cell death
was analyzed by ﬂow cytometry as determined by PI+
cells.
Western blotting analysis
The presence or absence of FADD, RIPK3, and RIPK1
protein was conﬁrmed by western blotting. Total sple-
nocytes were isolated from mice of the indicated geno-
types. MEFs were stimulated with 10 ng/ml TNFα for
indicated time points. Cell lysates were prepared in cold
RIPA lysis buffer containing 50mM Tris pH 8.0, 150mM
NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 1
mM phenylmethyl sulphonyl ﬂuoride, and 1x Halt pro-
tease inhibitor cocktail (Thermo Scientiﬁc, #78430).
Additional inhibitors were added when probing for
phospho-speciﬁc proteins (50 mM β-glycerophosphate, 1
mM sodium vanadate, 10 mM sodium ﬂuoride). Proteins
(40 μg) were separated on a 10% SDS-PAGE gel and
transferred to a nitrocellulose membrane. Proteins on the
membrane were stained with Ponceau S (Sigma-Aldrich,
#78376) as a loading/transfer control. Antibodies speciﬁc
for FADD (generated in house), RIPK3 (ProSci, #2283),
RIPK1 (BD Biosciences, #610459), p65 (Cell Signaling,
#3034), p44/42 MAPK (Erk1/2) (Cell signaling, #9102)
were incubated with the membrane overnight at 4 °C
followed by streptavidin-horseradish peroxidase (HRP)-
conjugated anti-rabbit (1/10,000,Vector laboratories #PI-
1000) or anti-mouse antibodies (1/10,000, Vector
laboratories #PI-2000). For analyses of TNF-induced sig-
naling, membranes were blocked with 5% BSA in TBST
for 1 h at room temperature and blotted overnight in 5%
BSA in TBST containing antibodies speciﬁc for phos-
phorylated forms of p65 NFκB (Cell signaling, #3033S),
Erk1/2(p42/44) (Cell signaling, #9106S). Membranes were
incubated with HRP-conjugated secondary antibodies at
room temperature for 1 h, followed by incubation with
Western Lightning Plus-ECL reagent (Perkin Elmer,
NEL105001EA). Chemiluminescent signals were detected
using X-ray ﬁlm or with ProteinSimple FluorChem M
imaging system (ProteinSimple).
Cell viability and caspase 3/7 activity
MEFs cells were seeded to 24-well plate (105 cells/well).
After overnight incubation (about 60% conﬂuence), TNFα
(50 ng/ml) and SYTOXTM Green (50 nM, Invitrogen,
S34860) and/or Caspase-3/7 red (5 μM, Essen bioscience,
#4440) were added and real-time analyses of cell death
responses were analyzed an IncuCyte instrument.
Statistical analysis
Data is represented as mean ± Standard error of the
mean (SEM). Student’s t-tests were performed using
Prism software v7.03 (Graphpad Software, Inc.) to deter-
mine p values. A p value < 0.05 was considered signiﬁcant.
Sequence alignment was performed using Geneious
Software (Geneious).
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